MLTX (MoonLake Corp) Earnings growth in current year

MLTX (MoonLake Corp) - company brandmark

MoonLake Immunotherapeutics (MLTX) maintains stability through experienced leadership and the transparency of its clinical data. The company's annual net income per share growth, as reflected in the daily price action on the GURU.Markets chart, is recorded at -1.10. While the business focuses on developing antibodies for psoriasis therapy, the company is currently spending its accumulated capital due to a lack of current sales during the research phase.

MLTX: MoonLake Immunotherapeutics Earnings per share growth in current year 04/28/2023 - 11/17/2026

Financial and market metric breakdowns for MoonLake Immunotherapeutics AG (MLTX)

- share price and expert price forecast:
Basic company analysis:MLTX - MoonLake Corp
Finished products of MoonLake

EPS dynamics reflect real operational efficiency by measuring the percentage change in earnings per share to identify fundamental business growth drivers. In the context of MoonLake Immunotherapeutics (MLTX), which is currently in the clinical trial phase, this metric on GURU.Markets ignores macroeconomics and focuses on the product cycle, allowing for an assessment of the year-over-year change in earnings per share as an indicator of investment risk.

Main competitors

ASND: Net earnings per one share growth for the current year|MDGL (Madrigal Corp) - Earnings growth in current year|Earnings growth in current year Corcept Therapeutics|Earnings growth in current year RYTM|Earnings per share growth in current year AKRO (Akero Therapeutics, Inc.)|Earnings per share growth in current year metsera.com MTSR|Crinetics Corp (CRNX) - Earnings per share growth rate in current year|NAMS - Earnings per share growth in current year|SLNO: Earnings per share growth in current year|FOLD: Earnings growth in current year|ETNB - Expected net earnings per share growth this year|Earnings per share growth in current year Agios Corp|Structure Corp (GPCR) - Expected net earnings per share growth this year|Earnings per share growth in current year mimedx.com (MDXG)|Net earnings per share growth this year rezolutebio.com RZLT|Earnings per share growth in current year Lexicon Pharmaceuticals, Inc. LXRX|MBX Bio - Earnings per share growth in current year|ALT: Net earnings per share growth this year|AARD - Earnings growth in current year|SGMT: Earnings growth in current year|Earnings per share growth rate in current year BioAge Labs, Inc. (BIOA)|Earnings per share growth in current year Biomea Fusion Inc|Earnings per share growth this year QNCX (Quince Therapeutics)|Net earnings per share growth this year GUTS (Fractyl Health)|Net earnings per one share growth for the current year VTVT|Agape ATP Corporation - Net earnings per share growth this year|Earnings per share increase in current year PLUR|Synlogic Inc. - Earnings growth in current year|LPCN (Lipocine) - Earnings per share growth this year|MTNB (Matinas BioPharma Holdings Inc.) - Net earnings per share growth this year|SPRB (Spruce Biosciences, Inc.) - Earnings per share growth in current year|GLTO (galecto.com) - Earnings growth in current year|Net earnings per share growth this year carmellrx.com (CTCX)|Earnings per share growth in current year Lumos Pharma (LUMO)|ONVO (Organovo Holdings) - Earnings per share increase in current year|radiuspharm.com - Net earnings per share growth this year